USFDA classifies inspection conducted at Cipla’s Goa facility as OAI

23 Jan 2020 Evaluate

United States Food and Drug Administration (USFDA) has classified the inspection conducted at Cipla’s Goa manufacturing facility from September 16-17, 2019 as Official Action Indicated (OAI). The Company will work closely with the agency to comprehensively address the observations received.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1242.65 -1.25 (-0.10%)
27-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.65
Dr. Reddys Lab 1281.95
Cipla 1242.65
Zydus Lifesciences 896.60
Lupin 2334.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×